Anatomical-Clinical Base of Adenocarcinoma Pancreatic
This project, called BACAP-2, is creating a valuable collection of biological samples and health information from people diagnosed with pancreatic adenocarcinoma, a common type of pancreatic cancer. Pancreatic cancer is a serious illness, and finding new treatments and better diagnostic tools is incredibly important. By gathering these samples, researchers hope to gain a deeper understanding of how pancreatic cancer develops and why some treatments work better than others. This collection will be used to explore new ways to detect the disease earlier, develop more effective medicines, and improve how we understand and fight this cancer. It's about supporting future research to make a real difference for patients.
At a glance
What is this study about?
Pancreatic cancer is a challenging illness, and sadly, it's often diagnosed at a later stage. The most common type is called adenocarcinoma, and currently, surgery is the main cure, but it's only an option for a small number of people. It's also hard to prevent or screen for because doctors don't yet have good ways to spot it early or identify who is most at risk.
This project, called BACAP-2, is all about helping researchers tackle these challenges. It's like building a valuable library of information and samples from people with pancreatic adenocarcinoma. This 'library' will include detailed health information alongside small pieces of tissue from the tumour. By studying these samples, scientists hope to learn more about the disease on a very detailed level.
The main goal is to strengthen an existing collection to support future research. This research will focus on several key areas: finding new ways to diagnose pancreatic cancer earlier, understanding exactly how these tumours grow and develop, discovering new treatments, and figuring out why certain existing treatments like chemotherapy work well for some people but not others. Ultimately, this will help doctors develop better tests and more effective treatments for pancreatic cancer.
Key takeaways
- This study helps build a collection for future pancreatic cancer research.
- It uses tumour tissue and medical information to understand the disease better.
- The goal is to find new ways to diagnose and treat pancreatic cancer.
- Participation involves donating samples during routine medical procedures.
- No extra hospital visits or medication are needed for this study.
- You can withdraw at any time without affecting your medical care.
Who may be eligible?
To be part of this study, you would need to be an adult, aged 18 to 120 years old, and have been diagnosed with pancreatic adenocarcinoma. This diagnosis would typically be confirmed by looking at tissue samples under a microscope.
The study is looking for people who have had their pancreatic mass investigated, either through an ultrasound scan with a small tissue sample taken (cytopuncture), or through an abdominal CT scan (with or without a special dye) and potentially a biopsy of the mass or other affected areas.
However, you wouldn't be able to join if your pancreatic tumour turned out not to be adenocarcinoma after analysis. Also, if you are pregnant or breastfeeding, you would not be able to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you an adult (18 years or older)?
- Have you been diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer)?
- Has your pancreatic mass been investigated by ultrasound or CT scan?
- Are you currently not pregnant or breastfeeding?
What does participation involve?
Taking part in this study primarily involves donating biological samples, specifically fresh tumour tissue. This usually happens when you are already undergoing a procedure where such tissue is collected for your normal medical care. The study will also collect existing clinical data from your medical records. There are no additional visits, medication, or follow-up appointments solely for the purpose of this biobank study beyond your standard medical care.
Potential risks and benefits
Locations (8)
- Béthune hospital centerVerified postcodeBéthune, France· Not yet recruiting
- Haut-Lévêque HospitalVerified postcodeBordeaux, France· Not yet recruiting
- Huriez HospitalVerified postcodeLille, France· Not yet recruiting
- Jean Mermoz private hosptilaVerified postcodeLyon, France· Not yet recruiting
- Saint Eloi HospitalVerified postcodeMontpellier, France· Not yet recruiting
- Regional Cancer Center From MontpellierVerified postcodeMontpellier, France· Not yet recruiting
- PAU hospitalVerified postcodePau, France· Not yet recruiting
- Rangueil hospitalVerified postcodeToulouse, France· Recruiting
Common questions
What is the main purpose of this study?
The study aims to create a collection of samples and information from people with pancreatic cancer to help researchers understand the disease better and find new ways to diagnose and treat it.
What kind of samples will be collected?
The study will collect fresh tumour tissue and health information from your medical records.
Will I need extra doctor's visits if I join?
No, there are no extra appointments or visits required for this study. Samples are collected during procedures you would already be having as part of your care.
Who can join this study?
Adults (18-120 years old) with a confirmed diagnosis of pancreatic adenocarcinoma are generally eligible.
What will my samples be used for?
Your samples will help scientists research new diagnostic tools, understand how tumours grow, and develop new treatments for pancreatic cancer.
How to find out more
Barbara BOURNET, MD, PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.